Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Pharmaceutics|August 10, 2021
Inhalation Delivery for the Treatment and Prevention of COVID-19 InfectionBasanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, et al.
The Annals of Thoracic Surgery|August 31, 2015
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung TransplantationDon Hayes, Sylvester M Black, Joseph D Tobias, et al.
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs|March 20, 2013
Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunctionDon Hayes, Mark Galantowicz, Andrew R Yates, et al.
Current Pharmaceutical Design|February 3, 2016
In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor ModelsMaria F Acosta, Priya Muralidharan, Samantha A Meenach, et al.
ACS Pharmacology & Translational Science|June 18, 2026
Kidney-Targeted Nanoparticle Delivery of Formoterol Mitigates Diabetic Kidney Disease without Adverse Cardiac EffectsErnest L Vallorz, Kristan Cleveland, Natalie E Scholpa, et al.
AAPS Pharmscitech|September 28, 2011
Sustained-release delivery of octreotide from biodegradable polymeric microspheresYun-Seok Rhee, MinJi Sohn, Byung H Woo, et al.
International Journal of Pharmaceutics|January 26, 2012
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticlesJinghua Duan, Heidi M Mansour, Yangde Zhang, et al.
Gels (Basel, Switzerland)|December 24, 2025
Engineering Inhalable Carboxymethyl Chitosan-Swellable Microgels for Pulmonary Delivery of Charged Hydrophilic MoleculesDavid Encinas-Basurto, Kiley McCombs, Ernest L Vallorz, et al.
Pageof 11